These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 790086)

  • 1. The role of glucagon-insulin interactions in control of glucose turnover and its significance in diabetes.
    Vranic M; Ross G; Doi K; Lickley L
    Metabolism; 1976 Nov; 25(11 Suppl 1):1375-80. PubMed ID: 790086
    [No Abstract]   [Full Text] [Related]  

  • 2. An important role for glucagon in the regulation of glucose production in vivo.
    Liljenquist JE; Chiassan JL; Cherrington AD; Keller U; Jennings AS; Bomboy JD; Lacy WW
    Metabolism; 1976 Nov; 25(11 Suppl 1):1371-3. PubMed ID: 979637
    [No Abstract]   [Full Text] [Related]  

  • 3. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine pancreas.
    Fujimoto WY; Ensinck JW; Williams RH
    Life Sci; 1974 Dec; 15(11):1999-2004. PubMed ID: 4621242
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man.
    Goldsmith SJ; Yalow RS; Berson SA
    Diabetes; 1970 Jun; 19(6):453-7. PubMed ID: 4393032
    [No Abstract]   [Full Text] [Related]  

  • 6. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats.
    Cejvan K; Coy DH; Efendic S
    Diabetes; 2003 May; 52(5):1176-81. PubMed ID: 12716749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon and the A cells.
    Unger RH; Raskin P; Srikant CB; Orci L
    Recent Prog Horm Res; 1976; 33():477-517. PubMed ID: 801196
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
    Greenbaum CJ; Havel PJ; Taborsky GJ; Klaff LJ
    J Clin Invest; 1991 Sep; 88(3):767-73. PubMed ID: 1679440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin and diabetes mellitus: the role of glucagon in diabetic hyperglycemia and glucose intolerance.
    Wahren J
    Scand J Clin Lab Invest; 1976 Oct; 36(6):497-503. PubMed ID: 1006141
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas.
    Honey RN; Fallon MB; Weir GC
    Metabolism; 1980 Dec; 29(12):1242-6. PubMed ID: 6109226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha cell function in diabetes mellitus.
    Gerich JE
    Metabolism; 1976 Nov; 25(11 Suppl 1):1513-6. PubMed ID: 790098
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraislet negative insulin-glucagon feedback.
    Samols E; Harrison J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1443-7. PubMed ID: 790090
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin and glucagon secretion from rat islets maintained in a tissue culture-perifusion system.
    Gingerich RL; Aronoff SL; Kipnis DM; Lacy PE
    Diabetes; 1979 Apr; 28(4):276-81. PubMed ID: 374172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of glucagon and insulin on the histochemical and functional alterations in the Langerhans islands after hepatectomy in dogs].
    Kanazawa H
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):535-42. PubMed ID: 1875894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon physiology in health and disease.
    Sherwin R; Felig P
    Int Rev Physiol; 1977; 16():151-71. PubMed ID: 332652
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin and glucagon release of human islets in vitro: effects of chronic exposure to glucagon.
    Bertuzzi F; Berra C; Socci C; Davalli AM; Pozza G; Pontiroli AE
    J Endocrinol; 1997 Feb; 152(2):239-43. PubMed ID: 9071981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM; Asplin CM; Palmer JP
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ; Porte D
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.